RAK Ghani Glass, one of the Middle East’s leading manufacturers of pharmaceutical glass packaging, is entering the European market with competitive rates on its high-quality lightweight USP type III amber bottles for the pharmaceutical and healthcare industry.
The company’s decision to launch into new territory, according to its sole UK and Republic of Ireland agent, Eurofusion, is indicative of the strengthening of the Middle East as a glass manufacturing centre due to government investment as part of a strategy to move away from dependency on the petrodollar, as well as the abundance of energy and raw materials in the region.
“The UAE’s low-cost business environment, coupled with RAK Ghani’s brand new, state-of-the-art production facility, allows us to offer UK and Republic of Ireland buyers this product, which conforms to all pharmaceutical industry standards and is delivered to the UK at highly competitive rates,” said Peter Scully, Managing Director of Eurofusion.
The company’s packaging is produced to US and EU pharmacopoeia standards. Bottles are available in both European standard and custom sizes, dimensions and finishes. All products are automatically inspected and packed in a Class 100,000 clean room environment.
For more than 15 years, RAK Ghani Glass’s parent company, Ghani Group, has been a market leader in the manufacture of float glass for the construction and automotive industries, as well as glass packaging for food, beverages and pharmaceutical products in the South Asia and Middle East and North Africa (MENA) regions.
